CH672230A5
(es)
*
|
1987-10-15 |
1989-11-15 |
Nestle Sa |
|
FR2634104B1
(fr)
*
|
1988-07-18 |
1991-10-18 |
Union Coop Agricole |
Hydrolysat partiel de proteines de lactoserum, procede enzymatique de preparation de cet hydrolysat, et aliment lacte dietetique hypoallergenique le contenant
|
DE4002204A1
(de)
*
|
1990-01-26 |
1991-08-01 |
Westfalen Milchwerke |
Diaetetisches nahrungsmittel fuer patienten mit niereninsuffizienz
|
NL9001692A
(nl)
*
|
1990-04-26 |
1991-11-18 |
Cooeperatieve Melkproductenbed |
Werkwijze voor de bereiding van een olie-in-water emulsie.
|
JP3065116B2
(ja)
*
|
1991-02-25 |
2000-07-12 |
株式会社第一化成 |
透明な乳清タンパク質加工品の製造法
|
JP3059595B2
(ja)
*
|
1992-11-20 |
2000-07-04 |
森永乳業株式会社 |
沈澱を生じない乳清蛋白質分解物の製造法
|
US5350590A
(en)
*
|
1992-12-15 |
1994-09-27 |
Beatreme Foods Inc. |
Protein fat replacer and method of manufacture thereof
|
US6051256A
(en)
*
|
1994-03-07 |
2000-04-18 |
Inhale Therapeutic Systems |
Dispersible macromolecule compositions and methods for their preparation and use
|
US6290991B1
(en)
|
1994-12-02 |
2001-09-18 |
Quandrant Holdings Cambridge Limited |
Solid dose delivery vehicle and methods of making same
|
US5965532A
(en)
*
|
1996-06-28 |
1999-10-12 |
Trustees Of Tufts College |
Multivalent compounds for crosslinking receptors and uses thereof
|
US20030203036A1
(en)
*
|
2000-03-17 |
2003-10-30 |
Gordon Marc S. |
Systems and processes for spray drying hydrophobic drugs with hydrophilic excipients
|
DK1493439T3
(da)
|
1997-04-02 |
2012-01-30 |
Brigham & Womens Hospital |
Middel til fastlæggelse af en persons risikoprofil for aterosklerotisk sygdom
|
AU771563C
(en)
|
1998-07-15 |
2004-10-28 |
Brigham And Women's Hospital |
Polysaccharide vaccine for staphylococcal infections
|
US6106874A
(en)
*
|
1998-11-18 |
2000-08-22 |
Abbott Laboratories |
Calcium fortified juice-based nutritional supplement and process of making
|
JP2004500090A
(ja)
|
2000-02-17 |
2004-01-08 |
ウェルチ・フーズ・インク |
カルシウム強化されたブドウに基づく生成物及びそれらの製造方法
|
EP1266013B1
(en)
|
2000-03-08 |
2014-10-15 |
Massachusetts Institute Of Technology |
Heparinase iii and uses thereof
|
US20030060487A1
(en)
*
|
2000-04-12 |
2003-03-27 |
Bamdad R. Shoshana |
Treatment of neurodegenerative disease
|
US7575761B2
(en)
*
|
2000-06-30 |
2009-08-18 |
Novartis Pharma Ag |
Spray drying process control of drying kinetics
|
AU2001277230A1
(en)
*
|
2000-08-01 |
2002-02-13 |
Inhale Therapeutic Systems, Inc. |
Apparatus and process to produce particles having a narrow size distribution andparticles made thereby
|
RU2174756C1
(ru)
*
|
2000-09-18 |
2001-10-20 |
Борисов Александр Борисович |
Пищевой продукт
|
DE10062056A1
(de)
*
|
2000-12-15 |
2002-07-04 |
Henkel Ecolab Gmbh & Co Ohg |
Verfahren zur Reinigung von Ionenaustauscher-Kunststoffharzen
|
DE60227691D1
(de)
|
2001-11-01 |
2008-08-28 |
Nektar Therapeutics |
Sprühtrocknungsverfahren
|
DE60221621T2
(de)
*
|
2001-11-26 |
2008-05-21 |
Nestec S.A. |
Lagerstabiles Nahrungsmittelprodukt enthaltend Molkenprotein, Verfahren zu seiner Herstellung und Verwendung
|
US20030165574A1
(en)
*
|
2002-03-01 |
2003-09-04 |
Ward Loren Spencer |
Compositions and methods for treatment of body weight conditions
|
JP4828795B2
(ja)
*
|
2002-03-11 |
2011-11-30 |
モメンタ ファーマシューティカルズ インコーポレイテッド |
硫酸化多糖類の分析
|
US7794965B2
(en)
|
2002-03-13 |
2010-09-14 |
Signum Biosciences, Inc. |
Method of identifying modulators of PP2A methylase
|
JP3833129B2
(ja)
*
|
2002-03-19 |
2006-10-11 |
株式会社Adeka |
濃縮牛乳状組成物
|
GB0216562D0
(en)
*
|
2002-04-25 |
2002-08-28 |
Bradford Particle Design Ltd |
Particulate materials
|
US9339459B2
(en)
|
2003-04-24 |
2016-05-17 |
Nektar Therapeutics |
Particulate materials
|
JP4808970B2
(ja)
|
2002-12-30 |
2011-11-02 |
ネクター セラピューティクス |
噴霧乾燥システム
|
US7399496B2
(en)
*
|
2003-02-07 |
2008-07-15 |
Glanbia Nutritionals (Ireland) Limited |
Hydrolyzed whey protein compositions
|
SI1897548T1
(sl)
|
2003-02-28 |
2013-12-31 |
The Johns Hopkins University |
Regulacija celic T
|
US8071645B2
(en)
|
2003-06-12 |
2011-12-06 |
The Regents Of The University Of Colorado |
Systems and methods for treating human inflammatory and proliferative diseases and wounds, with fatty acid metabolism inhibitors and/or glycolytic inhibitors
|
JP2007502991A
(ja)
|
2003-08-20 |
2007-02-15 |
バイオサイト インコーポレイテッド |
生物活性ナトリウム利尿ペプチドを測定するための、およびその治療可能性を向上させるための方法および組成物
|
US7355593B2
(en)
*
|
2004-01-02 |
2008-04-08 |
Smart Technologies, Inc. |
Pointer tracking across multiple overlapping coordinate input sub-regions defining a generally contiguous input region
|
US20050163887A1
(en)
*
|
2004-01-23 |
2005-07-28 |
Land O' Lakes, Inc. |
Method of producing heat stable whey protein and products made therefrom
|
US20070172474A1
(en)
*
|
2004-04-02 |
2007-07-26 |
University Of Tennessee Research Foundiation |
Dairy components effective for fat loss
|
WO2006020060A2
(en)
*
|
2004-07-15 |
2006-02-23 |
Tetralogic Pharmaceuticals Corporation |
Iap binding compounds
|
US8299083B2
(en)
|
2004-08-17 |
2012-10-30 |
The Johns Hopkins University |
PDE5 inhibitor compositions and methods for treating cardiac indications
|
US7893034B2
(en)
*
|
2004-09-02 |
2011-02-22 |
Yale University |
Regulation of oncogenes by microRNAs
|
US20080138847A1
(en)
*
|
2004-09-23 |
2008-06-12 |
Yigong Shi |
Bcl-2 family member and BH-3 only proteins for use in development of peptidomimetics
|
WO2006042192A2
(en)
|
2004-10-06 |
2006-04-20 |
The Brigham And Womens's Hospital, Inc. |
Relevance of achieved levels of markers of systemic inflammation following treatment
|
NZ537456A
(en)
*
|
2004-12-24 |
2007-10-26 |
Fonterra Co Operative Group |
Whey products and a process for preparing a modified whey protein concentrate
|
EP1843734A4
(en)
*
|
2005-02-03 |
2008-09-10 |
Signum Biosciences Inc |
COMPOSITIONS AND METHOD FOR INTENSIFYING COGNITIVE FUNCTIONS
|
US7923041B2
(en)
|
2005-02-03 |
2011-04-12 |
Signum Biosciences, Inc. |
Compositions and methods for enhancing cognitive function
|
WO2006091459A2
(en)
|
2005-02-24 |
2006-08-31 |
Joslin Diabetes Center, Inc. |
Compositions and methods for treating vascular permeability
|
US7517906B2
(en)
*
|
2005-02-25 |
2009-04-14 |
Tetralogic Pharmaceuticals Corporation |
Dimeric IAP inhibitors
|
EP1888086A4
(en)
*
|
2005-04-11 |
2009-09-16 |
Univ Tennessee Res Foundation |
STABLE MILK PRODUCT COMPONENTS WITH FAT REDUCING EFFECT
|
WO2007002528A1
(en)
*
|
2005-06-23 |
2007-01-04 |
Yale University |
Anti-aging micrornas
|
EP1906972B1
(en)
|
2005-07-19 |
2013-09-11 |
The University of Tennessee Research Foundation |
LPA2 receptor agonist for treating diarrhea
|
AU2006272497B2
(en)
|
2005-07-27 |
2012-07-19 |
University Of Florida Research Foundation, Inc. |
Small compounds that correct protein misfolding and uses thereof
|
US20100256046A1
(en)
*
|
2009-04-03 |
2010-10-07 |
Tetralogic Pharmaceuticals Corporation |
Treatment of proliferative disorders
|
WO2007021825A2
(en)
*
|
2005-08-09 |
2007-02-22 |
Tetralogic Pharmaceuticals Corporation |
Treatment of proliferative disorders
|
US20080021198A1
(en)
*
|
2005-10-12 |
2008-01-24 |
Yigong Shi |
Modulators of protein phosphatase 2A and PP2A methyl esterase
|
US8658608B2
(en)
*
|
2005-11-23 |
2014-02-25 |
Yale University |
Modified triple-helix forming oligonucleotides for targeted mutagenesis
|
JP2009518308A
(ja)
*
|
2005-12-01 |
2009-05-07 |
ユニヴァーシティ オヴ ピッツバーグ オヴ ザ コモンウェルス システム オヴ ハイアー エデュケーション |
アポトーシスを阻害するための化合物及び方法
|
CN101516904A
(zh)
*
|
2006-07-24 |
2009-08-26 |
泰特拉洛吉克药业公司 |
二聚的iap拮抗剂
|
US20100113326A1
(en)
*
|
2006-07-24 |
2010-05-06 |
Tetralogic Pharmaceuticals Corporation |
Dimeric iap inhibitors
|
US20100056495A1
(en)
*
|
2006-07-24 |
2010-03-04 |
Tetralogic Pharmaceuticals Corporation |
Dimeric iap inhibitors
|
WO2008014238A2
(en)
*
|
2006-07-24 |
2008-01-31 |
Tetralogic Pharmaceuticals Corporation |
Dimeric iap inhibitors
|
CL2007002166A1
(es)
*
|
2006-07-24 |
2008-01-25 |
Tetralogic Pharm Corp |
Compuestos derivados de heterociclos de nitrogeno, antagonistas de los inhibidores de las proteinas de la apoptosis; sus composiciones farmaceuticas; y uso de dichos compuestos para el tratamiento del cancer.
|
US20080153773A1
(en)
*
|
2006-08-08 |
2008-06-26 |
Yigong Shi |
Modulators of phosphotyrosyl phosphatase activator
|
US20100092480A1
(en)
*
|
2006-10-13 |
2010-04-15 |
The Trustees Of The University Of Princeton |
Modulators of protein phosphatase 2a
|
US7645616B2
(en)
*
|
2006-10-20 |
2010-01-12 |
The University Of Hong Kong |
Use of lipocalin-2 as a diagnostic marker and therapeutic target
|
AU2008205410B2
(en)
|
2007-01-05 |
2013-10-10 |
Massachusetts Institute Of Technology |
Compositions of and methods of using sulfatases from flavobacterium heparinum
|
US20100172882A1
(en)
*
|
2007-01-11 |
2010-07-08 |
Glazer Peter M |
Compositions and methods for targeted inactivation of hiv cell surface receptors
|
WO2008109773A2
(en)
*
|
2007-03-06 |
2008-09-12 |
Cornell Research Foundation, Inc. |
Chronic obstructive pulmonary disease susceptibility and related compositions and methods
|
WO2008116216A1
(en)
*
|
2007-03-22 |
2008-09-25 |
Medical College Of Georgia Research Institute, Inc. |
Compositions and methods for inhibiting cancer metastasis
|
WO2008122039A2
(en)
*
|
2007-04-02 |
2008-10-09 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Selenocysteine mediated hybrid antibody molecules
|
US9139876B1
(en)
|
2007-05-03 |
2015-09-22 |
Momenta Pharmacueticals, Inc. |
Method of analyzing a preparation of a low molecular weight heparin
|
ES2527648T3
(es)
|
2007-06-08 |
2015-01-28 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Métodos para determinar el subtipo de carcinoma hepatocelular
|
JP2009000091A
(ja)
*
|
2007-06-25 |
2009-01-08 |
Sanei Gen Ffi Inc |
抱気性乳清タンパク質の調製方法及び該方法によって調製される食品
|
US20090274682A1
(en)
*
|
2008-02-05 |
2009-11-05 |
The Trustees Of Princeton University |
Demethylation and inactivation of protein phosphatase 2a
|
US20090233858A1
(en)
*
|
2008-02-26 |
2009-09-17 |
The Trustees Of Princeton University |
Structure of a protein phosphatase 2a holoenzyme: insights into tau dephosphorylation
|
AU2009222056A1
(en)
*
|
2008-03-01 |
2009-09-11 |
Abraxis Bioscience, Llc |
Treatment, diagnostic, and method for discovering antagonist using SPARC specific miRNAs
|
CA2723716A1
(en)
*
|
2008-05-07 |
2009-11-12 |
Abraxis Bioscience, Llc |
Enhancement of drug therapy by mirna
|
WO2010017103A2
(en)
*
|
2008-08-04 |
2010-02-11 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Servic |
Fully human anti-human nkg2d monoclonal antibodies
|
AU2009293403A1
(en)
|
2008-09-17 |
2010-03-25 |
Tetralogic Pharmaceuticals Corp. |
IAP inhibitors
|
US8729053B2
(en)
*
|
2008-09-22 |
2014-05-20 |
The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services |
Nuclear factor kappa B pathway inhibitor composition and use of same
|
WO2010075303A1
(en)
|
2008-12-23 |
2010-07-01 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Splicing factors with a puf protein rna-binding domain and a splicing effector domain and uses of same
|
WO2010075417A1
(en)
|
2008-12-23 |
2010-07-01 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Survivin specific t cell receptor for treating cancer
|
US8309356B2
(en)
*
|
2009-04-01 |
2012-11-13 |
Yale University |
Pseudocomplementary oligonucleotides for targeted gene therapy
|
CA2759733C
(en)
|
2009-04-23 |
2019-09-03 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Anti-human ror1 antibodies
|
ES2675236T3
(es)
|
2009-04-30 |
2018-07-09 |
The U.S.A. As Represented By The Secretary, Department Of Health And Human Services |
Schweinfurthinas y usos de las mismas
|
WO2010132532A1
(en)
|
2009-05-15 |
2010-11-18 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
B cell surface reactive antibodies
|
IN2012DN00352A
(es)
|
2009-06-16 |
2015-08-21 |
Bikam Pharmaceuticals Inc |
|
US8283372B2
(en)
|
2009-07-02 |
2012-10-09 |
Tetralogic Pharmaceuticals Corp. |
2-(1H-indol-3-ylmethyl)-pyrrolidine dimer as a SMAC mimetic
|
WO2011011797A2
(en)
|
2009-07-24 |
2011-01-27 |
The Board Of Trustees Of The Leland Stanford Junior University |
Cytokine compositions and methods of use thereof
|
EP2287304A1
(en)
|
2009-08-17 |
2011-02-23 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Novel treatment of patients after stent implantation or balloon dilatation and novel drug eluting stents
|
EP2483301A1
(en)
|
2009-10-01 |
2012-08-08 |
The United States Of America, As Represented By The Secretary, Department of Health and Human Services |
Anti-vascular endothelial growth factor receptor-2 chimeric antigen receptors and use of same for the treatment of cancer
|
CN102791742B
(zh)
*
|
2010-01-19 |
2014-12-24 |
动量制药公司 |
评价肝素制剂
|
WO2011133802A1
(en)
|
2010-04-21 |
2011-10-27 |
Helix Therapeutics, Inc. |
Compositions and methods for treatment of lysosomal storage disorders
|
US20110262406A1
(en)
|
2010-04-21 |
2011-10-27 |
Yale University |
Compositions and methods for targeted inactivation of hiv cell surface receptors
|
EP2595613B1
(en)
|
2010-07-22 |
2019-01-09 |
The U.S.A. as represented by the Secretary, Department of Health and Human Services |
Compounds for use in a method of preventing or treating viral infection
|
AU2011336650B2
(en)
|
2010-12-01 |
2016-12-08 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Chimeric rabbit/human ROR1 antibodies
|
WO2012106591A1
(en)
|
2011-02-03 |
2012-08-09 |
Mirna Therapeutics, Inc. |
Synthetic mimics of mir-34
|
CN103459598B
(zh)
|
2011-02-03 |
2016-08-10 |
米尔纳医疗股份有限公司 |
Mir-124的合成模拟物
|
WO2012115952A1
(en)
|
2011-02-21 |
2012-08-30 |
Momenta Pharmaceuticals, Inc. |
Evaluating heparin preparations
|
WO2012125623A2
(en)
|
2011-03-14 |
2012-09-20 |
Ludwig Institute For Cancer Research Ltd. |
Cleavage inhibitors of transforming growth factor beta type i receptor and uses thereof in cancer therapy
|
CA2832540C
(en)
|
2011-04-08 |
2020-09-15 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Anti-epidermal growth factor receptor variant iii chimeric antigen receptors and use of same for the treatment of cancer
|
BR112013027057A2
(pt)
|
2011-04-21 |
2020-08-11 |
Trustees Of Tufts College |
composições e métodos para a estabilização de agentes ativos
|
CN103917093B
(zh)
|
2011-06-14 |
2017-08-11 |
比卡姆药品公司 |
视蛋白结合配体、组合物及使用方法
|
US8759313B2
(en)
|
2011-08-03 |
2014-06-24 |
The Charlotte-Mecklenburg Hospital Authority |
Treatment of fibrosis using microRNA 19b
|
SG10201608671SA
(en)
|
2011-07-18 |
2016-12-29 |
Harvard College |
Engineered Microbe-Targeting Molecules and Uses Thereof
|
US9499464B2
(en)
|
2011-10-19 |
2016-11-22 |
Bikam Pharmaceuticals, Inc. |
Opsin-binding ligands, compositions and methods of use
|
AU2012325915A1
(en)
|
2011-10-20 |
2014-04-24 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Anti-CD22 chimeric antigen receptors
|
AU2012346214B2
(en)
|
2011-11-30 |
2017-09-14 |
Bikam Pharmaceuticals, Inc. |
Opsin-binding ligands, compositions and methods of use
|
JP6322142B2
(ja)
|
2011-12-01 |
2018-05-09 |
ビカム ファーマスーティカルス,インコーポレイテッド |
オプシン結合性リガンド、組成物、及び使用方法
|
EP2828290B1
(en)
|
2012-03-23 |
2018-08-15 |
The United States of America, represented by the Secretary, Department of Health and Human Services |
Anti-mesothelin chimeric antigen receptors
|
US10076535B2
(en)
|
2012-04-27 |
2018-09-18 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Use of CPG oligonucleotides co-formulated with an antibiotic to accelerate wound healing
|
WO2013169691A1
(en)
|
2012-05-07 |
2013-11-14 |
Trustees Of Dartmouth College |
Anti-b7-h6 antibody, fusion proteins, and methods of using the same
|
WO2013187519A1
(ja)
*
|
2012-06-15 |
2013-12-19 |
森永乳業株式会社 |
改質ホエイ組成物の製造方法、改質ホエイ組成物、カルシウム増強改質ホエイ組成物の製造方法
|
WO2014031649A1
(en)
|
2012-08-21 |
2014-02-27 |
Genesys Research Institute |
Compositions and methods for treating or preventing anthracycline induced cardiotoxicity
|
JP6338252B2
(ja)
|
2012-10-24 |
2018-06-06 |
アメリカ合衆国 |
M971キメラ抗原受容体
|
DK2730170T3
(en)
|
2012-11-13 |
2016-05-30 |
Dmk Deutsches Milchkontor Gmbh |
Allergen-free food compositions
|
EP2931272A1
(en)
|
2012-12-12 |
2015-10-21 |
The Charlotte-Mecklenburg Hospital Authority D/B/A Carolinas Healthcare System |
Methods of treating hepatic fibrosis and associated diseases by regulating rev-erb activity
|
EP2931273A1
(en)
|
2012-12-12 |
2015-10-21 |
The Charlotte-Mecklenburg Hospital Authority D/B/A Carolinas Healthcare System |
Methods of treating portal hypertension
|
EP2971166B1
(en)
|
2013-03-14 |
2021-05-19 |
Children's Medical Center Corporation |
Psap peptide for treating cd36 expressing cancers
|
US20160046679A1
(en)
|
2013-03-15 |
2016-02-18 |
Trustees Of Tufts College |
Low molecular weight silk compositions and stabilizing silk compositions
|
US11376329B2
(en)
|
2013-03-15 |
2022-07-05 |
Trustees Of Tufts College |
Low molecular weight silk compositions and stabilizing silk compositions
|
US9790282B2
(en)
|
2013-03-25 |
2017-10-17 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Anti-CD276 polypeptides, proteins, and chimeric antigen receptors
|
WO2014162007A2
(en)
|
2013-04-04 |
2014-10-09 |
Ieo - Istituto Europeo Di Oncologia Srl |
Thymic stromal lymphopoietin fragments and uses thereof
|
WO2014182635A1
(en)
|
2013-05-08 |
2014-11-13 |
Baldwin Megan E |
Biomarkers for age-related macular degeneration (amd)
|
NZ714347A
(en)
|
2013-06-25 |
2020-01-31 |
Walter & Eliza Hall Inst Medical Res |
Method of treating intracellular infection
|
WO2015006543A1
(en)
|
2013-07-10 |
2015-01-15 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Method for predicting and detecting tumor metastasis in kidney cancer
|
MX2016005101A
(es)
|
2013-10-21 |
2017-01-09 |
Salk Inst For Biological Studi |
Factor de crecimiento de fibroblastos (fgf) 1 mutado y procedimientos de uso.
|
RU2701346C1
(ru)
|
2013-12-06 |
2019-09-25 |
Дзе Юнайтед Стейтс Оф Америка, Эз Репрезентед Бай Дзе Секретари, Департмент Оф Хелс Энд Хьюман Сёрвисез |
Химерные антигенные рецепторы, специфичные в отношении рецептора тимусного стромального лимфопоэтина, и способы их применения
|
WO2015090347A1
(en)
|
2013-12-16 |
2015-06-25 |
Nestec S.A. |
Newly identified peptides for use in the induction of oral tolerance in young mammals
|
EP3546474B1
(en)
|
2013-12-18 |
2021-07-07 |
President and Fellows of Harvard College |
Crp capture/detection of gram positive bacteria
|
EP3122369B1
(en)
|
2014-03-26 |
2022-08-31 |
Children's Medical Center Corporation |
Cyclic prosaposin peptides and uses thereof
|
US11918695B2
(en)
|
2014-05-09 |
2024-03-05 |
Yale University |
Topical formulation of hyperbranched polymer-coated particles
|
WO2015172153A1
(en)
|
2014-05-09 |
2015-11-12 |
Yale University |
Topical formulation of hyperbranched polyglycerol-coated particles thereof
|
JP6613304B2
(ja)
|
2014-09-17 |
2019-12-04 |
ザ ユナイテッド ステイツ オブ アメリカ, アズ リプレゼンテッド バイ ザ セクレタリー, デパートメント オブ ヘルス アンド ヒューマン サービシーズ |
抗cd276抗体(b7h3)
|
WO2016079527A1
(en)
|
2014-11-19 |
2016-05-26 |
Tetralogic Birinapant Uk Ltd |
Combination therapy
|
WO2016097773A1
(en)
|
2014-12-19 |
2016-06-23 |
Children's Cancer Institute |
Therapeutic iap antagonists for treating proliferative disorders
|
WO2016154585A1
(en)
|
2015-03-26 |
2016-09-29 |
Charles Sentman |
Anti-mica antigen binding fragments, fusion molecules, cells which express and methods of using
|
KR20180033499A
(ko)
|
2015-06-05 |
2018-04-03 |
아이바이오, 인크. |
섬유증을 치료하는데 사용하기 위한 엔도스타틴 단편 및 변이체
|
EP3831844B1
(en)
|
2015-06-26 |
2024-03-13 |
Prindex S.r.l. |
Diagnosis and therapy of multiple sclerosis
|
EP3313519B1
(en)
|
2015-06-29 |
2023-05-31 |
Children's Medical Center Corporation |
Jak-stat inhibitors for the treatment of congenital myopathies
|
US10435457B2
(en)
|
2015-08-06 |
2019-10-08 |
President And Fellows Of Harvard College |
Microbe-binding molecules and uses thereof
|
BR112018010659B1
(pt)
|
2015-12-18 |
2022-06-14 |
Société des Produits Nestlé S.A. |
Composição termicamente esterilizada, seu processo para sua preparação, e usos de proteína de soro do leite.
|
BR112018014615A2
(pt)
|
2016-01-20 |
2018-12-11 |
The Scripps Research Institute |
composições de anticorpo para ror1 e métodos relacionados
|
JP2019509023A
(ja)
|
2016-01-20 |
2019-04-04 |
ザ・スクリップス・リサーチ・インスティテュート |
Ror2抗体組成物及び関連する方法
|
JP2019508037A
(ja)
|
2016-02-16 |
2019-03-28 |
イェール ユニバーシティーYale Universit |
標的化遺伝子編集を増強するための組成物およびその使用方法
|
WO2017143061A1
(en)
|
2016-02-16 |
2017-08-24 |
Yale University |
Compositions and methods for treatment of cystic fibrosis
|
US10293005B2
(en)
|
2016-04-19 |
2019-05-21 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Use of gram negative species to treat atopic dermatitis
|
JP2019513769A
(ja)
|
2016-04-19 |
2019-05-30 |
ザ ユナイテッド ステイツ オブ アメリカ,アズ レプリゼンテッド バイ ザ セクレタリー,デパートメント オブ ヘルス アンド ヒューマン サービシーズ |
アトピー性皮膚炎を処置するためのグラム陰性種の使用
|
EP3458473B8
(en)
|
2016-05-16 |
2022-08-17 |
Checkmab S.R.L. |
Markers selectively deregulated in tumor-infiltrating regulatory t cells.
|
WO2017207623A1
(en)
|
2016-05-31 |
2017-12-07 |
Université de Lausanne |
Mirna as biomarkers and regulators of cancer stem cells
|
US20190322643A1
(en)
|
2016-06-29 |
2019-10-24 |
Georgia State University Research Foundation, Inc. |
Histone deacetylase and histone methyltransferase inhibitors and methods of making and use of the same
|
WO2018005759A1
(en)
|
2016-07-01 |
2018-01-04 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Inhibitor of heme degradation for use to improve antibiotic treatment of mycobacterium tuberculosis infection
|
ES2839455T3
(es)
*
|
2016-07-15 |
2021-07-05 |
Arla Foods Amba |
Método de producción de agregados de proteínas de suero de leche gelificable con ácido concentrados o secos, y composiciones y productos alimenticios afines
|
WO2018187493A1
(en)
|
2017-04-04 |
2018-10-11 |
Yale University |
Compositions and methods for in utero delivery
|
EP3655437A1
(en)
|
2017-07-20 |
2020-05-27 |
NBE-Therapeutics AG |
Human antibodies binding to ror2
|
MX2020001212A
(es)
|
2017-08-07 |
2020-03-20 |
Nbe Therapeutics Ag |
Conjugados anticuerpo-farmaco a base de antraciclina que tienen alta tolerabilidad in vivo.
|
US11197917B2
(en)
|
2017-12-01 |
2021-12-14 |
ByHeart, Inc. |
Formulations for nutritional support in subjects in need thereof
|
WO2019154884A1
(en)
|
2018-02-07 |
2019-08-15 |
Ecole Polytechnique Federale De Lausanne (Epfl) |
Method for determining cancer invasiveness and patient prognosis
|
EP3777567A4
(en)
*
|
2018-03-30 |
2022-01-26 |
Megmilk Snow Brand Co. Ltd. |
METHOD OF PREPARING A COMPOSITION CONTAINING KAPPA-CASEINGLYCOMACROPEPTIDE
|
US10973841B2
(en)
|
2018-05-11 |
2021-04-13 |
Forte Subsidiary, Inc. |
Compositions for the treatment of skin conditions
|
CN109045278B
(zh)
*
|
2018-07-09 |
2022-06-21 |
苏州恒瑞健康科技有限公司 |
一种稳定的乳蛋白质液态体系及其应用
|
US11266617B2
(en)
|
2018-10-16 |
2022-03-08 |
Massachusetts Institute Of Technology |
Beta-hydroxybutyrate encapsulated PLGA nanoparticle compositions
|
CN112912497B
(zh)
|
2018-10-19 |
2024-01-12 |
德克萨斯州大学系统董事会 |
工程化长散在元件(line)转座子及其使用方法
|
CN113226465A
(zh)
|
2018-12-19 |
2021-08-06 |
雀巢产品有限公司 |
用于预防或减少经皮水分流失并改善皮肤屏障功能的组合物
|
EP3677693A1
(en)
|
2019-01-03 |
2020-07-08 |
Ecole Polytechnique Federale De Lausanne (EPFL) EPFL-TTO |
Transpochimeric gene trancripts (tcgts) as cancer biomarkers
|
JOP20210194A1
(ar)
|
2019-01-18 |
2023-01-30 |
Janssen Biotech Inc |
مستقبلات المستضدات الخيمرية لـ gprc5d وخلايا تعبر عنها
|
EP3918607A1
(en)
|
2019-01-30 |
2021-12-08 |
Janssen Pharmaceutica NV |
Methods of treating prostate cancer based on molecular subtypes
|
US20220054494A1
(en)
|
2019-03-13 |
2022-02-24 |
University Of Pittsburgh - Of The Commonwealth System Of Higher Education |
Methods for treating bladder and urethra dysfunction and disease
|
US20220160771A1
(en)
|
2019-04-10 |
2022-05-26 |
Iulia Diaconu |
Flt3-specific chimeric antigen receptors and methods of using the same
|
AU2020280105A1
(en)
|
2019-05-22 |
2022-01-20 |
Massachusetts Institute Of Technology |
Circular RNA compositions and methods
|
WO2020239478A1
(en)
|
2019-05-28 |
2020-12-03 |
Pharma Mar, S.A. |
Trabectedin for treating sarcomas based on genomic markers
|
WO2020257776A1
(en)
|
2019-06-21 |
2020-12-24 |
Yale University |
Peptide nucleic acid compositions with modified hoogsteen binding segments and methods of use thereof
|
WO2020257779A1
(en)
|
2019-06-21 |
2020-12-24 |
Yale University |
Hydroxymethyl-modified gamma-pna compositions and methods of use thereof
|
TW202118788A
(zh)
|
2019-07-26 |
2021-05-16 |
美商健生生物科技公司 |
包含血管舒緩素相關肽酶2抗原結合域之蛋白質及其用途
|
EP4004055A1
(en)
|
2019-07-26 |
2022-06-01 |
Janssen Biotech, Inc. |
Anti-hk2 chimeric antigen receptor (car)
|
WO2021022161A1
(en)
|
2019-07-31 |
2021-02-04 |
Yale University |
Compositions and methods for treating sickle cell disease
|
CN112390894A
(zh)
|
2019-08-12 |
2021-02-23 |
广东东阳光药业有限公司 |
嵌合抗原受体及其应用
|
KR20220041934A
(ko)
|
2019-08-16 |
2022-04-01 |
얀센 바이오테크 인코포레이티드 |
개선된 기능을 갖는 치료용 면역 세포 및 이의 제조 방법
|
CA3161825A1
(en)
|
2019-11-18 |
2021-05-27 |
Janssen Biotech, Inc. |
Anti-cd79 chimeric antigen receptors, car-t cells, and uses thereof
|
US20230051969A1
(en)
*
|
2019-12-30 |
2023-02-16 |
Arla Foods Amba |
Method of producing dense whey protein nanogels, the resulting whey protein nanogels or nanogel compositions, and food products containing such whey protein nanogels or nanogel compositions
|
IL271778A
(en)
|
2019-12-31 |
2021-06-30 |
Ichilov Tech Ltd |
Methods for treating atopic dermatitis
|
EP3868396A1
(en)
|
2020-02-20 |
2021-08-25 |
Enthera S.R.L. |
Inhibitors and uses thereof
|
KR20220154728A
(ko)
|
2020-03-13 |
2022-11-22 |
얀센 바이오테크 인코포레이티드 |
Siglec-3/cd33을 결합시키기 위한 물질 및 방법
|
US20230181672A1
(en)
|
2020-05-07 |
2023-06-15 |
The U.S.A., As Represented By The Secretary, Department Of Health And Human Services |
Aberrant post-translational modifications (ptms) in methyl- and propionic acidemia and a mutant sirtuin (sirt) to metabolize ptms
|
WO2021236855A1
(en)
|
2020-05-19 |
2021-11-25 |
Orna Therapeutics, Inc. |
Circular rna compositions and methods
|
WO2021245285A1
(en)
|
2020-06-05 |
2021-12-09 |
Janssen Pharmaceutica Nv |
Methods of treating prostate cancer based on molecular subtypes
|
CN116615256A
(zh)
|
2020-10-16 |
2023-08-18 |
乔治亚大学研究基金会 |
糖缀合物
|
IL306103A
(en)
|
2021-03-24 |
2023-11-01 |
Janssen Biotech Inc |
The antibody targets CD22 and CD79B
|
WO2022237974A1
(en)
|
2021-05-12 |
2022-11-17 |
Ecole Polytechnique Federale De Lausanne (Epfl) |
Krab-containing zinc finger protein and cancer
|
CN115404240A
(zh)
|
2021-05-28 |
2022-11-29 |
上海环码生物医药有限公司 |
制备环形rna的构建体、方法及其用途
|
WO2022261115A1
(en)
|
2021-06-07 |
2022-12-15 |
Yale University |
Peptide nucleic acids for spatiotemporal control of crispr-cas binding
|
WO2022271955A1
(en)
|
2021-06-23 |
2022-12-29 |
Musc Foundation For Research Development |
Novel targeted shrna nanoparticles for cancer therapy
|
WO2023046322A1
(en)
|
2021-09-24 |
2023-03-30 |
Janssen Pharmaceutica Nv |
Proteins comprising cd20 binding domains, and uses thereof
|
TW202334080A
(zh)
|
2021-11-08 |
2023-09-01 |
美商歐納醫療公司 |
用於遞送環狀聚核苷酸之脂質奈米粒子組合物
|
WO2023231959A2
(en)
|
2022-05-30 |
2023-12-07 |
Shanghai Circode Biomed Co., Ltd |
Synthetic circular rna compositions and methods of use thereof
|
WO2024102730A1
(en)
|
2022-11-08 |
2024-05-16 |
Orna Therapeutics, Inc. |
Lipids and nanoparticle compositions for delivering polynucleotides
|
WO2024102762A1
(en)
|
2022-11-08 |
2024-05-16 |
Orna Therapeutics, Inc. |
Lipids and lipid nanoparticle compositions for delivering polynucleotides
|